Industry News

Jan 31, 2014
By BioPharm International Editors
EMD Millipore's expands its Emprove raw materials portfolio to include 400 products.
Jan 31, 2014
By BioPharm International Editors
International Society for Pharmaceutical Engineering will continue strategic plan initiated by Nancy Berg; search begins for replacement.
Jan 28, 2014
By BioPharm International Editors
Novozymes Biopharma has released new study data on extending the serum half-life of albumin in vivo.
Jan 24, 2014
By BioPharm International Editors
FDA adds Ranbaxy's Toansa, India facility to existing consent decree, prohibiting distribution of APIs from that location
Jan 23, 2014
By BioPharm International Editors
In 2013, the EMA's Committee for Medicinal Products for Human Use recommended 81 medicines for human use for marketing authorization, compared with 57 in 2012.
Jan 17, 2014
By BioPharm International Editors
CCBR–SYNARC and BioClinica merge to create a provider of specialized outsourced clinical services.
Jan 17, 2014
By BioPharm International Editors
USP opens expanded Shanghai facility to enhance quality standards for medicines and food ingredients.
Jan 17, 2014
By BioPharm International Editors
Lonza signs an agreement with Index Ventures for the development and manufacture of biologics for portfolio companies.
Jan 17, 2014
By BioPharm International Editors
Novasep selects Thierry van Nieuwenhove as new president of the synthesis business unit.
Jan 17, 2014
By BioPharm International Editors
Combined technologies from Agilent Technologies and Picometrics Technologies are designed for large–molecule analysis.
native1_300x100
lorem ipsum